rethinkTHC Search
Menu
Study breakdown

Neuroinflammation May Connect the Endocannabinoid System to Drug Addiction

ReviewPreliminary evidence
The takeaway

A review of 165 studies found that drug addiction involves both disrupted endocannabinoid signaling and neuroinflammation, but whether these changes are causally connected remains unclear.

Read this if you want to understand how brain inflammation might connect to drug addiction.

165 studies reviewed linking endocannabinoid disruption, neuroinflammation, and addiction

What the researchers found

The review synthesized evidence from 165 articles showing that substance dependence is accompanied by both changes in endocannabinoid signaling and activation of neuroinflammatory processes. Specifically, disruption of cannabinoid signaling during addiction appears to lead to microglial activation (the brain's immune cells becoming active) and increased production of inflammatory cytokines.

Endocannabinoids normally act as immunomodulators by inhibiting cytokine production and microglial activation. When addiction disrupts this system, the resulting loss of anti-inflammatory endocannabinoid tone may contribute to the neuroinflammation observed in chronic substance users.

The review proposes that cannabinoids could potentially treat addiction in part through their anti-inflammatory and neuroprotective properties, though this remains theoretical.

Why it matters

If neuroinflammation is a meaningful component of addiction pathology, then anti-inflammatory interventions could represent a new therapeutic approach. The endocannabinoid system sits at the intersection of inflammation and reward processing, making it a uniquely positioned therapeutic target.

The numbers in context

165 articles reviewed. Evidence covered: microglial activation, cytokine changes, endocannabinoid signaling disruption, and interactions between these systems during drug addiction.

How the study worked

An evidence-based review of the literature was conducted, searching PubMed and BioMedCentral databases up to April 2014 with no date restrictions using the terms addiction, cannabinoids, and inflammation. 165 eligible articles were included.

What this study cannot tell us

The evidence is largely correlational and preclinical. It remains uncertain whether endocannabinoid changes and neuroinflammation are causally or coincidentally associated with addiction. Human data is limited. The theoretical framework connecting these systems has not been validated through clinical intervention studies.

How to read the evidence

This is a narrative review of primarily preclinical evidence. The proposed mechanistic links are plausible but unproven in humans.

When this study was published

Published in 2014. The neuroinflammation hypothesis of addiction has gained traction with additional supporting evidence since.

The bigger picture

Addiction has traditionally been understood through reward and dopamine-centric models. The neuroinflammation hypothesis adds another dimension, suggesting that brain immune activation contributes to the cycle of addiction. The endocannabinoid system's dual role in both reward and immune regulation makes it a compelling mechanistic link between these processes.

Questions still open

  • Would anti-inflammatory treatments reduce relapse risk in addiction? Can endocannabinoid-based therapies simultaneously address both the reward and inflammatory components of addiction? Does neuroinflammation drive addiction progression or is it a consequence?

Common questions

What is neuroinflammation?
It refers to inflammation specifically within the brain and nervous system, involving activation of microglia (the brain's immune cells) and production of inflammatory molecules called cytokines. It is observed in many brain disorders including addiction.
How could cannabinoids help with addiction?
The endocannabinoid system naturally suppresses neuroinflammation. If addiction disrupts this system and causes harmful brain inflammation, then restoring endocannabinoid tone could potentially reduce the neuroinflammatory component of addiction, though this remains theoretical.

Read the original research

Neuroinflammation as a possible link between cannabinoids and addiction.

Acta neuropsychiatrica, 26(6), 334-46

Citation

Rodrigues, Livia C M; Gobira, Pedro H; de Oliveira, Antonio Carlos; Pelição, Renan; Teixeira, Antonio Lucio; Moreira, Fabricio A; Campos, Alline Cristina. (2014). Neuroinflammation as a possible link between cannabinoids and addiction.. Acta neuropsychiatrica, 26(6), 334-46. https://doi.org/10.1017/neu.2014.24

Explore the wider topic